8/31/2020 9:02:58 AM
Ligand Begins Previously Announced Cash Tender Offer To Acquire Pfenex
8/24/2020 8:37:54 AM
Ligand : Amgen's KYPROLIS Approved By FDA As Combination Regimen
with DARZALEX And Dexamethasone For R/R MM
8/7/2020 8:34:23 AM
Ligand: CStone Report OmniAb-derived Anti-PD-L1 MAb CS1001 Plus Chemotherapy Met Pre-specified Primary Endpoint
8/3/2020 7:37:58 AM
Ligand Pharmaceuticals Inc (LGND) Has Raised Its FY20 Revenue Estimate To $165 Mln From $140 Mln
8/3/2020 7:37:18 AM
Ligand Pharmaceuticals Inc (LGND) Has Raised Its FY20 EPS Estimate To 4.10 From 3.65
8/3/2020 7:33:46 AM
Ligand Pharma Q2 Net Income $22.1 Mln Or $1.32/Shr Vs Loss Of $14.4 Mln Or $0.74/shr Last Year
6/15/2020 8:39:05 AM
Ligand Says Vernalis Research Expands Oncology Research Collaboration With Servier
5/29/2020 8:06:45 AM
Ligand Reports Icagen's Expansion Of Collaboration With Roche To Develop Therapies For Neurological Diseases
5/6/2020 7:12:58 PM
Ligand Pharmaceuticals Inc (LGND) Has Raised Its 2020 EPS Estimate To 3.65 From 3.62
5/6/2020 7:12:17 PM
Ligand Pharmaceuticals Inc (LGND) Has Raised Its 2020 Revenue Estimate To $140 Mln From $133 Mln
5/6/2020 5:21:32 PM
Ligand Pharma Q1 Loss/share $1.46 Vs. Profit $31.32 Year Ago
2/27/2020 8:03:49 AM
Ligand Now Expects 2020 Total Revenues To Be About $133 Mln And EPS To Be $3.62